210 related articles for article (PubMed ID: 6588972)
41. The interaction of lipolysis products of very low density lipoprotein with plasma high density lipoprotein (HDL): perfusate HDL with plasma HDL subfractions.
Tam SP; Breckenridge WC
Biochem Cell Biol; 1987 Mar; 65(3):252-60. PubMed ID: 3580175
[TBL] [Abstract][Full Text] [Related]
42. Changes in the plasma lipoprotein distribution of apolipoproteins C-II, C-III1, C-III2 and apolipoprotein B after heparin-induced lipolysis.
Nestel PJ; Huff MW; Billington T; Fidge NH
Biochim Biophys Acta; 1982 Jul; 712(1):94-102. PubMed ID: 7115750
[TBL] [Abstract][Full Text] [Related]
43. Effect of the combination of methyltestosterone and esterified estrogens compared with esterified estrogens alone on apolipoprotein CIII and other apolipoproteins in very low density, low density, and high density lipoproteins in surgically postmenopausal women.
Chiuve SE; Martin LA; Campos H; Sacks FM
J Clin Endocrinol Metab; 2004 May; 89(5):2207-13. PubMed ID: 15126543
[TBL] [Abstract][Full Text] [Related]
44. Studies on the mechanism of hypertriglyceridemia in Tangier disease. Determination of plasma lipolytic activities, k1 values and apolipoprotein composition of the major lipoprotein density classes.
Wang CS; Alaupovic P; Gregg RE; Brewer HB
Biochim Biophys Acta; 1987 Jul; 920(1):9-19. PubMed ID: 3109493
[TBL] [Abstract][Full Text] [Related]
45. Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice.
Zhong S; Goldberg IJ; Bruce C; Rubin E; Breslow JL; Tall A
J Clin Invest; 1994 Dec; 94(6):2457-67. PubMed ID: 7989603
[TBL] [Abstract][Full Text] [Related]
46. Nascent very-low-density lipoprotein triacylglycerol hydrolysis by lipoprotein lipase is inhibited by apolipoprotein E in a dose-dependent manner.
Jong MC; Dahlmans VE; Hofker MH; Havekes LM
Biochem J; 1997 Dec; 328 ( Pt 3)(Pt 3):745-50. PubMed ID: 9396715
[TBL] [Abstract][Full Text] [Related]
47. Ex vivo measurement of lipoprotein lipase-dependent very low density lipoprotein (VLDL)-triglyceride hydrolysis in human VLDL: an alternative to the postheparin assay of lipoprotein lipase activity?
Pruneta V; Autran D; Ponsin G; Marcais C; Duvillard L; Verges B; Berthezene F; Moulin P
J Clin Endocrinol Metab; 2001 Feb; 86(2):797-803. PubMed ID: 11158049
[TBL] [Abstract][Full Text] [Related]
48. Lipoprotein composition as a component in the lipoprotein clearance defect in experimental diabetes.
O'Looney P; Irwin D; Briscoe P; Vahouny GV
J Biol Chem; 1985 Jan; 260(1):428-32. PubMed ID: 3965456
[TBL] [Abstract][Full Text] [Related]
49. Determination of apolipoprotein B in apolipoprotein CII/CIII-containing lipoproteins by an immunoenzymmetric assay.
Sandkamp M; Tambyrajah BM; Assmann G; Schriewer H
Eur J Clin Chem Clin Biochem; 1992 Apr; 30(4):223-8. PubMed ID: 1525253
[TBL] [Abstract][Full Text] [Related]
50. Catabolism of very low density lipoproteins in experimental nephrosis.
Garber DW; Gottlieb BA; Marsh JB; Sparks CE
J Clin Invest; 1984 Oct; 74(4):1375-83. PubMed ID: 6480830
[TBL] [Abstract][Full Text] [Related]
51. Very low density lipoprotein. Removal of Apolipoproteins C-II and C-III-1 during lipolysis in vitro.
Eisenberg S; Patsch JR; Sparrow JT; Gotto AM; Olivecrona T
J Biol Chem; 1979 Dec; 254(24):12603-8. PubMed ID: 227902
[TBL] [Abstract][Full Text] [Related]
52. VLDL substrate properties and efficiency of their metabolic transformation by LPL.
Dergunov AD; Shuvaev VV; Perova NV
Experientia; 1989 May; 45(5):461-3. PubMed ID: 2721636
[TBL] [Abstract][Full Text] [Related]
53. Apolipoprotein VLDL-II inhibits lipolysis of triglyceride-rich lipoproteins in the laying hen.
Schneider WJ; Carroll R; Severson DL; Nimpf J
J Lipid Res; 1990 Mar; 31(3):507-13. PubMed ID: 2111369
[TBL] [Abstract][Full Text] [Related]
54. Effects of plasma apolipoproteins on lipoprotein lipase-mediated lipolysis of small and large lipid emulsions.
Yamamoto M; Morita SY; Kumon M; Kawabe M; Nishitsuji K; Saito H; Vertut-Doï A; Nakano M; Handa T
Biochim Biophys Acta; 2003 Jun; 1632(1-3):31-9. PubMed ID: 12782148
[TBL] [Abstract][Full Text] [Related]
55. The catabolism of very low density lipoproteins.
Breckenridge WC
Can J Biochem Cell Biol; 1985 Aug; 63(8):890-7. PubMed ID: 3904951
[TBL] [Abstract][Full Text] [Related]
56. Very low density lipoprotein. Dissociation of apolipoprotein C during lipoprotein lipase induced lipolysis.
Glangeaud MC; Eisenberg S; Olivecrona T
Biochim Biophys Acta; 1976 Jan; 486(1):23-35. PubMed ID: 12835
[TBL] [Abstract][Full Text] [Related]
57. Apolipoprotein CIII deficiency prevents the development of hypertriglyceridemia in streptozotocin-induced diabetic mice.
Takahashi T; Hirano T; Okada K; Adachi M
Metabolism; 2003 Oct; 52(10):1354-9. PubMed ID: 14564689
[TBL] [Abstract][Full Text] [Related]
58. Radioimmunoassay of human apolipoprotein CII. A study in normal and hypertriglyceridemic subjects.
Kashyap ML; Srivastava LS; Chen CY; Perisutti CG; Campbell M; Lutmer RF; Glueck CJ
J Clin Invest; 1977 Jul; 60(1):171-80. PubMed ID: 194919
[TBL] [Abstract][Full Text] [Related]
59. Metabolism of apolipoproteins CII, CIII1, CIII2 and VLDL-B in human subjects consuming high carbohydrate diets.
Huff MW; Nestel PJ
Metabolism; 1982 May; 31(5):493-8. PubMed ID: 6952065
[TBL] [Abstract][Full Text] [Related]
60. Demonstration of an abnormality of C apoprotein of very low density lipoprotein in patients with gout.
Macfarlane DG; Midwinter CA; Dieppe PA; Bolton CH; Hartog M
Ann Rheum Dis; 1985 Jun; 44(6):390-4. PubMed ID: 4015201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
